Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience.

Haemophilia : the official journal of the World Federation of Hemophilia - 1 Jan 2006

Carcao M, St Louis J, Poon M-C, Grunebaum E, Lacroix S, Stain A M, Blanchette V S, Rivard G E

Abstract excerpt

When a high titre inhibitor develops in a patient with haemophilia, attempts are made to eradicate it through immune tolerance induction therapy (ITI) involving the frequent and regular administration of factor, usually for months to years. ITI is successful in only two thirds of patients prompti...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Rituximab
Share to Antibodies, Monoclonal, Murine-Derived
Share to Clinical Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Administration Schedule

Share to Factor VIII

Share to Hemophilia A

Share to Immune Tolerance

Share to Immunologic Factors

Source

Identifiers

PMID: 16409170
DOI: 10.1111/j.1365-2516.2005.01170.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16409170-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience.PMID 16409170Read ↗

Inhibitors in haemophilia: pathophysiology.Semantic proximity Read ↗

Extensive bleeding due to an inhibitor in a haemophilia A patient with a Tyr2105Cys mutation: elimination of the inhibitor with rituximab.Semantic proximity Read ↗

Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors.Semantic proximity Read ↗

Key issues in inhibitor management in patients with haemophilia.Semantic proximity Read ↗

Treatment of patients with haemophilia and inhibitory antibodies.Semantic proximity Read ↗

Prophylactic recombinant factor VIIa in haemophilia patients with inhibitorsSemantic proximity Read ↗

Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres.Semantic proximity Read ↗

Spontaneous disappearance of high titre factor VIII inhibitor 15 years after unsuccessful ITI.Semantic proximity Read ↗

Development of anaphylactic shock in haemophilia B patients with inhibitors.Semantic proximity Read ↗

Inhibitors in haemophilia B: the Italian experienceSemantic proximity Read ↗

Immune tolerance in children with factors VIII and IX inhibitors: a single centre experience.Semantic proximity Read ↗

Immune tolerance induction with recombinant factor VIII in hemophilia A patients with high responding inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.